HANGZHOU, China – Hangzhou Singclean Medical Products Co., Ltd., a leading innovator in absorbable biomaterials and medical aesthetic solutions, has announced its participation in two major international exhibitions in September 2026: Dubai Derma 2026 in the United Arab Emirates and Medical Fair Asia 2026 in Singapore.
Dubai Derma 2026
Singclean Medical will exhibit at the 25th edition of the Dubai World Dermatology and Laser Conference and Exhibition (Dubai Derma), taking place from September 8–10, 2026 at the Dubai World Trade Centre (DWTC), UAE. Dubai Derma has emerged as the leading scientific skincare event in the Middle East, North Africa, and the Indian Subcontinent, attracting professionals from across the globe to explore the latest advancements in dermatology and aesthetics.

The company will showcase its advanced aesthetic portfolio, including:
- HA Dermal Fillers – cross-linked hyaluronic acid formulations for facial contouring and wrinkle correction
- Skin Boosters – for deep skin hydration, improved elasticity, and overall skin quality
- Biostimulators – PLLA-based collagen stimulators for long-term regenerative benefits
- Natural Skincare – PDRN-based solutions designed to improve skin quality and support natural aesthetic outcomes
Medical Fair Asia 2026
Immediately following Dubai Derma, Singclean Medical will participate in Medical Fair Asia 2026, Southeast Asia's leading international healthcare trade fair, from September 9–11, 2026 at Marina Bay Sands, Singapore. Visitors can meet the Singclean team at Booth No. Hall MBS 2P24.

At the Singapore exhibition, Singclean will present its comprehensive medical solutions, including:
- HA for Bone Joint – hyaluronic acid products for osteoarthritis and joint health
- Absorbable Hemostatic Agents – innovative wound care solutions
- Singfilter® – filtration and separation medical devices
- SingClean™ – the company's flagship medical product line
Global Regulatory Certifications
Singclean's products are backed by rigorous quality standards and have received approvals from multiple international regulatory authorities, including NMPA (China), MHRA (UK), HSA (Singapore), CE MDR (Europe), TGA (Australia), COFEPRIS (Mexico), ANVISA (Brazil), and DIGEMID (Peru).
Global Reach
With solutions popular in over 80 countries and regions, Singclean Medical continues to expand its global footprint. The company operates Asia's largest automated cross-linked HA gel production workshop, ensuring consistent quality and supply capacity to meet growing international demand.
Both exhibitions provide strategic platforms for Singclean to strengthen partnerships with local distributors and medical professionals, advancing its commitment to delivering high-quality, innovative medical and aesthetic solutions worldwide.
About Hangzhou Singclean Medical Products Co., Ltd.
Founded in 2002, Singclean Medical is dedicated to the innovation of absorbable biomaterials and ranks among the top three Chinese manufacturers and one of the world's leading innovators in this industry. The company provides a comprehensive portfolio of medical sodium hyaluronate gel products, chitosan products, and other biomaterial solutions.
Hangzhou Singclean Medical Products Co., Ltd.
Email: support@singclean.net
Phone: 0086571-63431868-8019
-
singclean | 2026-08-21
Singclean’s Medical Sodium Hyaluronate Gel for Bone Joint Gained EU MDR CE Certification, Ranking Among First 3 Globally! 协合医疗骨科医用透明质酸钠凝胶成功斩获欧盟MDR CE认证!跻身全球前三!This achievement sets multiple industry records: it is the first MDR CE certificate for hyaluronic acid-based orthopedic products ever issued by DNV worldwide. Singclean Medical has become the first Chinese company to obtain such certification in this category and has successfully ranked among the first 3 companies globally to secure a viscosupplementation MDR CE certificate. This accomplishment underscores Singclean Medical's technological expertise and international competitiveness in the field of orthopedic biomaterials and hyaluronic acid applications. 此次认证创造了多项行业纪录:这是DNV在全球范围内签发的首张透明质酸骨科类MDR CE证书;协合医疗为中国首家获此证书的企业,更成功跻身全球前三。这一成绩,充分彰显了协合医疗在骨科生物医用材料及透明质酸领域的技术积累与国际竞争力。 -
singclean | 2026-08-21
Singclean Medical’s 2nd International Aesthetic Medicine Leadership Summit Concludes Successfully in Shanghai Shanghai, August 27, 2026 – The 2nd International Aesthetic Medicine Leadership Summit, hosted by Singclean Medical, was held at W Shanghai – The Bund, within the IMCAS China Congress venue. Under the theme “Global Vision, Opening a New Chapter,” the summit served as a cross‑border, multi‑disciplinary platform for professional exchange, gathering an impressive lineup of leading physicians and global partners. -
singclean | 2026-08-21
Singclean Medical to Debut Singderm® at IMCAS China 2026 – A PreviewShanghai, August 2026 – The 5th IMCAS China Congress is set to open on August 27–29, 2026 at the W Shanghai – The Bund. As one of the most anticipated gatherings in medical aesthetics, the event will bring together global experts, innovators, and clinicians. Among the featured exhibitors, Hangzhou Singclean Medical Products Co., Ltd. will make a strong impression by unveiling its premium hyaluronic acid filler Singderm® to the international community.